silybin has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ascione, B; Careddu, G; Carlo-Stella, C; Dupuis, ML; Locatelli, SL; Malorni, W; Marconi, M; Matarrese, P; Ortona, E; Pagano, MT; Pierdominici, M | 1 |
1 other study(ies) available for silybin and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Estrogen Receptor beta; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Myocytes, Cardiac; Silybin; Xenograft Model Antitumor Assays | 2022 |